These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26959013)

  • 1. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
    Zhou X; Yu S; Su J; Sun L
    Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
    Zhang W; Zhang SL; Hu X; Tam KY
    Int J Biol Sci; 2015; 11(12):1390-400. PubMed ID: 26681918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
    Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.
    Chen W; Komuniecki PR; Komuniecki R
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
    Sradhanjali S; Reddy MM
    Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse mechanisms of inhibition of pyruvate dehydrogenase kinase by structurally distinct inhibitors.
    Mann WR; Dragland CJ; Vinluan CC; Vedananda TR; Bell PA; Aicher TD
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):283-92. PubMed ID: 11004568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global view of cognate kinase activation by the human pyruvate dehydrogenase complex.
    Guevara EL; Yang L; Birkaya B; Zhou J; Nemeria NS; Patel MS; Jordan F
    Sci Rep; 2017 Feb; 7():42760. PubMed ID: 28230160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
    Tso SC; Qi X; Gui WJ; Wu CY; Chuang JL; Wernstedt-Asterholm I; Morlock LK; Owens KR; Scherer PE; Williams NS; Tambar UK; Wynn RM; Chuang DT
    J Biol Chem; 2014 Feb; 289(7):4432-43. PubMed ID: 24356970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.
    Tso SC; Lou M; Wu CY; Gui WJ; Chuang JL; Morlock LK; Williams NS; Wynn RM; Qi X; Chuang DT
    J Med Chem; 2017 Feb; 60(3):1142-1150. PubMed ID: 28085286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.
    Jung ME; Byun BJ; Kim HM; Lee JY; Park JH; Lee N; Son YH; Choi SU; Yang KM; Kim SJ; Lee K; Kim YC; Choi G
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2719-23. PubMed ID: 27106709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities.
    Li Y; Xie Z; Lei X; Yang X; Huang S; Yuan W; Deng X; Wang Z; Tang G
    Bioorg Chem; 2024 Mar; 144():107160. PubMed ID: 38301426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
    Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S
    Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
    Korotchkina LG; Sidhu S; Patel MS
    Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
    Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
    PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.
    Sampson PB; Liu Y; Patel NK; Feher M; Forrest B; Li SW; Edwards L; Laufer R; Lang Y; Ban F; Awrey DE; Mao G; Plotnikova O; Leung G; Hodgson R; Mason JM; Wei X; Kiarash R; Green E; Qiu W; Chirgadze NY; Mak TW; Pan G; Pauls HW
    J Med Chem; 2015 Jan; 58(1):130-46. PubMed ID: 24867403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.
    Jeoung NH
    Diabetes Metab J; 2015 Jun; 39(3):188-97. PubMed ID: 26124988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.